Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi
Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine
Status: Enrolling
Updated:  2/28/2017
Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi
Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine
Status: Enrolling
Updated: 2/28/2017
Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Status: Enrolling
Updated:  3/6/2017
Louisiana State University Health
mi
from
Shreveport, LA
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Status: Enrolling
Updated: 3/6/2017
Louisiana State University Health
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients
A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients
Status: Enrolling
Updated:  3/8/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients
A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients
Status: Enrolling
Updated: 3/8/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety Study of the Aethlon Hemopurifier
A Clinical Safety Study of the Aethlon Hemopurifier® in Chronic ESRD Patients With HCV Infection
Status: Enrolling
Updated:  3/13/2017
DaVita Med Center Dialysis
mi
from
Houston, TX
Safety Study of the Aethlon Hemopurifier
A Clinical Safety Study of the Aethlon Hemopurifier® in Chronic ESRD Patients With HCV Infection
Status: Enrolling
Updated: 3/13/2017
DaVita Med Center Dialysis
mi
from
Houston, TX
Click here to add this to my saved trials
Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy Study 1. Phase I Study of Feasibility and Safety.
Status: Enrolling
Updated:  3/20/2017
Duke University
mi
from
Durham, NC
Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy Study 1. Phase I Study of Feasibility and Safety.
Status: Enrolling
Updated: 3/20/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects
A Single Dose, Open Label, Randomized, Balanced, Crossover Study to Assess the Relative Bioavailability of ThreeFormulations and Food Effect on GSK1322322 in Healthy Subjects
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
mi
from
Minneapolis, MN
A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects
A Single Dose, Open Label, Randomized, Balanced, Crossover Study to Assess the Relative Bioavailability of ThreeFormulations and Food Effect on GSK1322322 in Healthy Subjects
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Mercy Medical Center
mi
from
Baltimore, MD
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Mercy Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Inland Empire Liver Foundation
mi
from
Rialto, CA
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Inland Empire Liver Foundation
mi
from
Rialto, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
University of California at San Francisco
mi
from
San Francisco, CA
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Kaiser Permanente Medical Center
mi
from
San Francisco, CA
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Kaiser Permanente Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
University of Colorado Denver
mi
from
Aurora, CO
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Yale University
mi
from
New Haven, CT
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Orlando Va Medical Center
mi
from
Orlando, FL
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Orlando Va Medical Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Emory University
mi
from
Atlanta, GA
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Duke Clinical Research Institute
mi
from
Durham, NC
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Duke Clinical Research Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Lehigh Valley Health Network
mi
from
Allentown, PA
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Lehigh Valley Health Network
mi
from
Allentown, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Local Institution
mi
from
Buenos Aires, Bs As,
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Local Institution
mi
from
Buenos Aires, Bs As,
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
University of Colorado at Denver
mi
from
Denver, CO
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
University of Colorado at Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated:  3/22/2017
Emory Hospital Midtown Infectious Disease Clinic
mi
from
Atlanta, GA
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
Status: Enrolling
Updated: 3/22/2017
Emory Hospital Midtown Infectious Disease Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices
Testing Spread and Implementation of Novel MRSA-Reducing Practices
Status: Enrolling
Updated:  3/28/2017
Maine Medical Center
mi
from
Portland, ME
Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices
Testing Spread and Implementation of Novel MRSA-Reducing Practices
Status: Enrolling
Updated: 3/28/2017
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
Investigation of Immune Disorders and Deficiencies
Investigation of Molecular, Genetic and Cellular Mechanisms of Human Immune Disorders and Deficiencies
Status: Enrolling
Updated:  4/3/2017
O&O Alpan
mi
from
Fairfax, VA
Investigation of Immune Disorders and Deficiencies
Investigation of Molecular, Genetic and Cellular Mechanisms of Human Immune Disorders and Deficiencies
Status: Enrolling
Updated: 4/3/2017
O&O Alpan
mi
from
Fairfax, VA
Click here to add this to my saved trials
Evaluation of the QuantiFERON-TB Test.
Status: Enrolling
Updated:  4/3/2017
Oregon Health and Sciences University
mi
from
Portland, OR
Evaluation of the QuantiFERON-TB Test.
Status: Enrolling
Updated: 4/3/2017
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Monovalent Ebola Zaire Vaccine (rVSVN4CT1-EBOVGP1) Delivered by Intramuscular Injection in Healthy Adult Subjects
Status: Enrolling
Updated:  4/3/2017
Optimal Research, LLC
mi
from
Melbourne, FL
Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Monovalent Ebola Zaire Vaccine (rVSVN4CT1-EBOVGP1) Delivered by Intramuscular Injection in Healthy Adult Subjects
Status: Enrolling
Updated: 4/3/2017
Optimal Research, LLC
mi
from
Melbourne, FL
Click here to add this to my saved trials
Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection
A Double-Blind, Randomized, Placebo-Controlled, Trial of Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line Associated Bloodstream Infection (CLABSI) in Children and Adolescents
Status: Enrolling
Updated:  4/4/2017
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection
A Double-Blind, Randomized, Placebo-Controlled, Trial of Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line Associated Bloodstream Infection (CLABSI) in Children and Adolescents
Status: Enrolling
Updated: 4/4/2017
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection
A Double-Blind, Randomized, Placebo-Controlled, Trial of Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line Associated Bloodstream Infection (CLABSI) in Children and Adolescents
Status: Enrolling
Updated:  4/4/2017
Royal Children's Hospital Melbourne
mi
from
Parkville,
Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection
A Double-Blind, Randomized, Placebo-Controlled, Trial of Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line Associated Bloodstream Infection (CLABSI) in Children and Adolescents
Status: Enrolling
Updated: 4/4/2017
Royal Children's Hospital Melbourne
mi
from
Parkville,
Click here to add this to my saved trials
Retrospective Analysis of Veritas in Breast Reconstruction
Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)
Status: Enrolling
Updated:  4/4/2017
Mark M. Mofid, MD
mi
from
San Diego, CA
Retrospective Analysis of Veritas in Breast Reconstruction
Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)
Status: Enrolling
Updated: 4/4/2017
Mark M. Mofid, MD
mi
from
San Diego, CA
Click here to add this to my saved trials
Retrospective Analysis of Veritas in Breast Reconstruction
Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)
Status: Enrolling
Updated:  4/4/2017
Michael Meininger, MD
mi
from
Troy, MI
Retrospective Analysis of Veritas in Breast Reconstruction
Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)
Status: Enrolling
Updated: 4/4/2017
Michael Meininger, MD
mi
from
Troy, MI
Click here to add this to my saved trials
Retrospective Analysis of Veritas in Breast Reconstruction
Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)
Status: Enrolling
Updated:  4/4/2017
Martin Lacey, MD
mi
from
St. Paul, MN
Retrospective Analysis of Veritas in Breast Reconstruction
Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)
Status: Enrolling
Updated: 4/4/2017
Martin Lacey, MD
mi
from
St. Paul, MN
Click here to add this to my saved trials
Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
Surveillance for the Effectiveness and Safety of Artemether-lumefantrine in Pediatric and Adult Patients With Malaria
Status: Enrolling
Updated:  4/6/2017
Centers for Disease Control and Prevention,GA
mi
from
Atlanta, GA
Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
Surveillance for the Effectiveness and Safety of Artemether-lumefantrine in Pediatric and Adult Patients With Malaria
Status: Enrolling
Updated: 4/6/2017
Centers for Disease Control and Prevention,GA
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Fresno, CA
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
San Diego, CA
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Stanford, CA
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Hartford, CT
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Washington,
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Gainesville, FL
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Miami, FL
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Chicago, IL
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Maywood, IL
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Peoria, IL
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Duluth, MN
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Duluth, MN
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Omaha, NE
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Neptune, NJ
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Winston Salem, NC
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Cleveland, OH
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Columbus, OH
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Dayton, OH
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
Clinical Research Facility
mi
from
Houston, TX
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated:  4/6/2017
mi
from
Herston,
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status: Enrolling
Updated: 4/6/2017
mi
from
Herston,
Click here to add this to my saved trials